Inventaire - your friends and communities are your best library

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

author

Pascal Poignard

Dennis R. Burton

1931 -

published in: Nature Medicine

date of publication: 2009-06-07

language: English

main subject: antibody

Cites articles 36

Date

Title

Authors

2008-11-12

Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals

John R. Mascola, George M. Shaw, Richard T. Wyatt, James A Hoxie, Mark K. Louder
2008-11-05

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

Leonidas Stamatatos, Noah Sather, Spyros A Kalams
2008-10-15

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

John R. Mascola, Jens Wrammert, Claire W Hallahan, Rafi Ahmed, Nicole Doria-Rose, Martha Nason, Bimal K. Chakrabarti, Richard T. Wyatt, Sijy O'Dell, Stephen A Migueles, Rachel G. Klein
2008-09-01

HIV-1 transmission, by stage of infection

Deirdre Hollingsworth, Roy M. Anderson
2007-09-01

Fc receptor but not complement binding is important in antibody protection against HIV.

Paul Whi Parren, Dennis R. Burton, Donald N Forthal
2007-08-26

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

John R. Mascola, George M. Shaw, Richard T. Wyatt, Mark K. Louder
2007-04-04

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors

George M. Shaw, Dennis R. Burton, Robert W. Doms, Guido Vanham
2007-02-15

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Joseph Sodroski, Gary Nabel, Peter D. Kwong, Dennis R. Burton, Tongqing Zhou, James Arthos, Richard T. Wyatt, Ann J Hessell, Mei-Yun Zhang, Sutapa Dey Barna, Donald Van Ryk, Xinzhen Yang
2007-01-24

Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication

Levi Yant, Thomas C. Friedrich, David I Watkins
2007-08-01

Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention
2007-07-20

Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes
2006-09-01

Which topical microbicides for blocking HIV-1 transmission will work in the real world?

Robin Shattock, Per Johan Klasse, John P. Moore
2006-05-01

The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication

Mary Carrington, Randall Johnson, Levi Yant, Thomas C. Friedrich, David H. O’Connor, David I Watkins
2006-08-01

Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates
2005-07-19

Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges

Ira Longini
2005-03-30

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

Oliver Laeyendecker, Fred Wabwire-Mangen, Nelson Sewankambo, Fred Nalugoda, Noah Kiwanuka, Godfrey Kigozi, Maria J Wawer, David Serwadda, Ronald H Gray, Thomas C. Quinn, Mohammed G Kiddugavu, Thomas Lutalo
2005-10-01

Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.
2004-12

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Bette Korber, Renate Kunert, Christos J Petropoulos, Dennis R. Burton
2004-04-28

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Myron S. Cohen, Joseph J Eron, Christopher D Pilcher
2004-12-09

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates
2003-05-01

Defining the Protective Antibody Response for HIV-1

John R. Mascola
2003-04-01

Rapid evolution of the neutralizing antibody response to HIV type 1 infection
2003-08-01

Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge,Transient early post‐inoculation anti‐retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut‐associated lymphoid tissues in SIVmac239‐infected rhesus macaques, but not resistance to rechallenge
2002-03-01

Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies

Nancy Haigwood
2001-12-01

Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

Paul Whi Parren
2001-09-01

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
2001-02-01

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)
2001-03-01

Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model

Myron S. Cohen, Joseph J Eron, Robert W Coombs, Susan A Fiscus
2000-02

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Deborah L. Birx, John R. Mascola
2000-02-01

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
1999-05-01

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies

Deborah L. Birx, John R. Mascola
1999-02-01

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys

Nancy Haigwood

Article - wd:Q35101333

Welcome to Inventaire

the library of your friends and communities

learn more